lercanidipine has been researched along with Arteriosclerosis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Accomazzo, MR; Bernini, F; Canavesi, M; Catapano, AL; Corsini, A; Fumagalli, R; Paoletti, R; Sartani, A; Testa, R | 1 |
| Baetta, R; Barberi, L; Catapano, AL; Comparato, C; Donetti, E; Farina, P; Leonardi, A; Natali, M; Soma, MR | 1 |
| Bellosta, S; Bernini, F | 1 |
1 review(s) available for lercanidipine and Arteriosclerosis
| Article | Year |
|---|---|
Lipophilic calcium antagonists in antiatherosclerotic therapy.
Topics: Arteriosclerosis; Calcium Channel Blockers; Cardiovascular System; Cell Division; Cell Movement; Dihydropyridines; Endothelium; Humans; Lipid Metabolism; Macrophages; Muscle, Smooth; Myocardium | 2000 |
3 other study(ies) available for lercanidipine and Arteriosclerosis
| Article | Year |
|---|---|
[Also for problem cases; successful first line therapy].
Topics: Antihypertensive Agents; Arteriosclerosis; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Humans; Hypertension; Treatment Outcome | 2005 |
The new calcium antagonist lercanidipine and its enantiomers affect major processes of atherogenesis in vitro: is calcium entry involved?
Topics: Animals; Antihypertensive Agents; Arteriosclerosis; Brain; Calcium Channel Blockers; Cell Division; Dihydropyridines; In Vitro Techniques; Male; Membranes; Muscle, Smooth, Vascular; Nitrendipine; Rats; Rats, Sprague-Dawley; Stereoisomerism | 1998 |
Effect of lercanidipine and its (R)-enantiomer on atherosclerotic lesions induced in hypercholesterolemic rabbits.
Topics: Animals; Arteries; Arteriosclerosis; Calcium Channel Blockers; Cholesterol, Dietary; Dihydropyridines; Disease Models, Animal; Hypercholesterolemia; Hyperplasia; Macrophages; Male; Rabbits | 1998 |